D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 70 Citations 13,978 208 World Ranking 1090 National Ranking 587
Medicine D-index 71 Citations 14,458 223 World Ranking 14736 National Ranking 7650

Overview

What is she best known for?

The fields of study she is best known for:

  • Gene
  • Antibody
  • Immune system

Her primary areas of investigation include Virology, Plasmodium falciparum, Antibody, Antigen and Malaria. Carole A. Long interconnects Immunology, Immune system, Immunogenicity and Parasitemia in the investigation of issues within Virology. Carole A. Long has researched Plasmodium falciparum in several fields, including Immunoglobulin G, Immunity and Microbiology.

Her Antibody research integrates issues from Heterologous and Plasmodium yoelii. Her Antigen research includes themes of Neutralizing antibody, Monoclonal antibody and Recombinant DNA. In general Malaria study, her work on Apicomplexa and Plasmodium vivax often relates to the realm of Basigin, thereby connecting several areas of interest.

Her most cited work include:

  • Erratum: Corrigendum: The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody (642 citations)
  • Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51 (340 citations)
  • In Vitro Studies with Recombinant Plasmodium falciparum Apical Membrane Antigen 1 (AMA1): Production and Activity of an AMA1 Vaccine and Generation of a Multiallelic Response (233 citations)

What are the main themes of her work throughout her whole career to date?

Her primary scientific interests are in Plasmodium falciparum, Virology, Antigen, Antibody and Immunology. Her Plasmodium falciparum study incorporates themes from Recombinant DNA and Vaccination. Her Virology study integrates concerns from other disciplines, such as Immune system, Immunity, Immunogenicity, Plasmodium yoelii and Epitope.

Her Antigen research is multidisciplinary, relying on both T cell, Molecular biology, Monoclonal antibody and Microbiology. Her work on Immunoglobulin G, Antibody titer and Immunization as part of her general Antibody study is frequently connected to Merozoite surface protein, thereby bridging the divide between different branches of science. Her work in the fields of Adjuvant, Parasitemia, Acquired immune system and Humoral immunity overlaps with other areas such as CpG site.

She most often published in these fields:

  • Plasmodium falciparum (61.87%)
  • Virology (60.43%)
  • Antigen (46.04%)

What were the highlights of her more recent work (between 2018-2021)?

  • Antibody (46.04%)
  • Plasmodium falciparum (61.87%)
  • Antigen (46.04%)

In recent papers she was focusing on the following fields of study:

Carole A. Long focuses on Antibody, Plasmodium falciparum, Antigen, Malaria and Virology. Her Antibody research is multidisciplinary, incorporating perspectives in Molecular biology and Malaria vaccine. Her work deals with themes such as Parasitology, Monoclonal antibody, Immunization and Recombinant DNA, which intersect with Plasmodium falciparum.

In the subject of general Antigen, her work in Immunogenicity is often linked to Monophosphoryl Lipid A, thereby combining diverse domains of study. The various areas that Carole A. Long examines in her Malaria study include Interquartile range and Arbitrary unit. Her studies deal with areas such as Endemic area, Transmission blocking and Sterility as well as Virology.

Between 2018 and 2021, her most popular works were:

  • Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies. (40 citations)
  • A defined mechanistic correlate of protection against Plasmodium falciparum malaria in non-human primates (18 citations)
  • A Universal Plug-and-Display Vaccine Carrier Based on HBsAg VLP to Maximize Effective Antibody Response. (17 citations)

In her most recent research, the most cited papers focused on:

  • Gene
  • Antibody
  • Immune system

Carole A. Long mainly investigates Antibody, Plasmodium falciparum, Malaria, Antigen and Virology. Her Antibody research focuses on Recombinant DNA and how it connects with Adjuvant, Bivalent, Immunofluorescence and Molecular biology. Her Plasmodium falciparum research is multidisciplinary, incorporating elements of Internal medicine, Interquartile range, Gastroenterology, Blot and Serology.

Her research investigates the connection between Malaria and topics such as Immune system that intersect with problems in Plasmodium berghei. Her Antigen research is multidisciplinary, relying on both Liposome and Immunity. Her Virology study combines topics in areas such as Malaria vaccine and Monoclonal antibody.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Erratum: Corrigendum: The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody

A D Douglas;A R Williams;J J Illingworth;G Kamuyu.
Nature Communications (2013)

993 Citations

Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51

Yimin Wu;Ruth D. Ellis;Donna Shaffer;Erica Fontes.
PLOS ONE (2008)

412 Citations

In Vitro Studies with Recombinant Plasmodium falciparum Apical Membrane Antigen 1 (AMA1): Production and Activity of an AMA1 Vaccine and Generation of a Multiallelic Response

Michael C. Kennedy;Jin Wang;Yanling Zhang;Aaron P. Miles.
Infection and Immunity (2002)

297 Citations

Phase 1 Clinical Trial of Apical Membrane Antigen 1: an Asexual Blood-Stage Vaccine for Plasmodium falciparum Malaria

Elissa M. Malkin;David J. Diemert;Julie H. McArthur;John R. Perreault.
Infection and Immunity (2005)

288 Citations

Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria.

Elissa M. Malkin;Anna P. Durbin;David J. Diemert;Jetsumon Sattabongkot.
Vaccine (2005)

261 Citations

The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody

Alexander D. Douglas;Andrew R. Williams;Joseph J. Illingworth;Gathoni Kamuyu.
Nature Communications (2011)

251 Citations

Vaccination of Monkeys with Recombinant Plasmodium falciparum Apical Membrane Antigen 1 Confers Protection against Blood-Stage Malaria

Anthony W. Stowers;Michael C. Kennedy;Brian P. Keegan;Allan Saul.
Infection and Immunity (2002)

230 Citations

Passive immunization against murine malaria with an IgG3 monoclonal antibody.

W R Majarian;T M Daly;W P Weidanz;C A Long.
Journal of Immunology (1984)

211 Citations

Immunity to Recombinant Plasmodium falciparum Merozoite Surface Protein 1 (MSP1): Protection in Aotus nancymai Monkeys Strongly Correlates with Anti-MSP1 Antibody Titer and In Vitro Parasite-Inhibitory Activity

Sanjay Singh;Kazutoyo Miura;Hong Zhou;Olga Muratova.
Infection and Immunity (2006)

207 Citations

Phase 1/2a Study of the Malaria Vaccine Candidate Apical Membrane Antigen-1 (AMA-1) Administered in Adjuvant System AS01B or AS02A

Michele D. Spring;James F. Cummings;Christian F. Ockenhouse;Sheetij Dutta.
PLOS ONE (2009)

205 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Carole A. Long

James G. Beeson

James G. Beeson

Burnet Institute

Publications: 174

Adrian V. S. Hill

Adrian V. S. Hill

University of Oxford

Publications: 84

Simon J. Draper

Simon J. Draper

University of Oxford

Publications: 78

Takafumi Tsuboi

Takafumi Tsuboi

Ehime University

Publications: 71

Michael Theisen

Michael Theisen

Statens Serum Institut

Publications: 69

Anthony A. Holder

Anthony A. Holder

The Francis Crick Institute

Publications: 66

Ivo Mueller

Ivo Mueller

Walter and Eliza Hall Institute of Medical Research

Publications: 66

Alan F. Cowman

Alan F. Cowman

Walter and Eliza Hall Institute of Medical Research

Publications: 63

David L. Narum

David L. Narum

National Institutes of Health

Publications: 63

Freya J. I. Fowkes

Freya J. I. Fowkes

Burnet Institute

Publications: 61

Michael F. Good

Michael F. Good

Griffith University

Publications: 60

Patrick E. Duffy

Patrick E. Duffy

National Institutes of Health

Publications: 58

Jack S. Richards

Jack S. Richards

Burnet Institute

Publications: 58

Sarah C. Gilbert

Sarah C. Gilbert

University of Oxford

Publications: 58

Kevin Marsh

Kevin Marsh

University of Oxford

Publications: 57

Robin F. Anders

Robin F. Anders

La Trobe University

Publications: 57

Trending Scientists

Kang-Won Lee

Kang-Won Lee

IBM (United States)

Chengbin Chu

Chengbin Chu

École Supérieure d'Ingénieurs en Électrotechnique et Électronique

Guang-Zhong Yang

Guang-Zhong Yang

Shanghai Jiao Tong University

I-Ming Chen

I-Ming Chen

Nanyang Technological University

William Lewis

William Lewis

University of Sydney

Marc R. Wilkins

Marc R. Wilkins

University of New South Wales

James W. Posakony

James W. Posakony

University of California, San Diego

Matthew T. Webster

Matthew T. Webster

Science for Life Laboratory

David W. Hoskin

David W. Hoskin

Dalhousie University

Ihsan S. Al-Aasm

Ihsan S. Al-Aasm

University of Windsor

Sardar Khan

Sardar Khan

University of Peshawar

Werner Eugster

Werner Eugster

ETH Zurich

Nicholas Chiorazzi

Nicholas Chiorazzi

Feinstein Institute for Medical Research

Vincent Deubel

Vincent Deubel

Institut Pasteur

Mark H. Ashcraft

Mark H. Ashcraft

University of Nevada, Las Vegas

Something went wrong. Please try again later.